Clinical trial
A Multicenter, Open-label Trial to Assess the Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Diabetic Neuropathy
NCT00220337 is registered in ClinicalTrials.gov with UCB Pharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Open-label Trial to Assess the Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Diabetic Neuropathy
- Lead sponsor
- UCB Pharma
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 21, 2004
- Completion date
- October 31, 2007
- Enrollment
- 371 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
painful diabetic neuropathy